 |
Page History
| Excerpt |
|---|
Of all the genomic aberrations recently observed in tumors by the TCGA program, which are expressed at the protein level? The Clinical Proteomic Tumor Analysis Consortium (CPTAC) has begun to answer this question. With this endeavor come a number of informatics challenges, not the least of which is integrating genomic and proteomic data from a common tumor. Dr. Kinsinger will highlight findings, software tools, and data resources developed to support the next era of omics research. |
BIO:
Chris Kinsinger, Ph.D., serves as a technology program manager for NCI’s Clinical Proteomic Tumor Analysis Consortium. Dr. Kinsinger focuses on the expansion and coordination of open data access and programmatic goals involving mass spectrometry, informatics, and biospecimens. In this role, he works with NCI staff and investigators to optimize proteomics technology, establish policies for sharing data and biospecimens, and generally improve the quality and reliability of proteomic measurements. Dr. Kinsinger completed postdoctoral training at National Institute of Standards and Technology (NIST), where he researched fragmentation pathways of peptide ions in mass spectrometry. He holds a Ph.D. degree in chemistry (2004) from the University of Minnesota.
...
